The Autoimmune Registry Releases Comprehensive List of Autoimmune Diseases
source: pixabay.com

The Autoimmune Registry Releases Comprehensive List of Autoimmune Diseases

According to a story from PR Newswire, The Autoimmune Registry, Inc. (ARI) has recently released its first ever autoimmune diseases list. This list includes a total of over 150 distinct…

Continue Reading The Autoimmune Registry Releases Comprehensive List of Autoimmune Diseases

Early Ocrelizumab Treatment Benefits Patients with Primary Progressive MS, Extension Study Shares

Did you know that there are multiple forms of multiple sclerosis (MS)? The most common form of MS is relapsing-remitting, meaning patients go through symptomatic periods and periods of remission.…

Continue Reading Early Ocrelizumab Treatment Benefits Patients with Primary Progressive MS, Extension Study Shares

Scientists Have Discovered An Immune Cell That May Partially Reverse Damage Caused by ALS and MS

A series of articles recently published in FierceBiotech describe a discovery by Ohio State and Michigan University scientists. The teams have discovered an immune cell that could be tapped to…

Continue Reading Scientists Have Discovered An Immune Cell That May Partially Reverse Damage Caused by ALS and MS

New Test Developed to Better Assess the Efficacy of Spinocerebellar Ataxia Type 3 Therapies

Researchers at the Mayo Clinic have collaborated with the international community to develop a potential way to test for spinocerebellar ataxia type 3 (SCA3), also called Machado-Joseph Disease. Additionally, they…

Continue Reading New Test Developed to Better Assess the Efficacy of Spinocerebellar Ataxia Type 3 Therapies
A Simple Sugar Could Be the Key to Treating Multiple Sclerosis
source: pixabay.com

A Simple Sugar Could Be the Key to Treating Multiple Sclerosis

In conditions like multiple sclerosis or neuromyelitis optica, disease progression is spurred by the destruction of myelin, the protective coating around nerve cells. However, new research suggests that N-acetylglucosamine, a…

Continue Reading A Simple Sugar Could Be the Key to Treating Multiple Sclerosis
Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis
source: pixabay.com

Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis

A study reported in NewsWise evaluates retinoid-x receptor (RXR) agonists as a treatment for recurring and refractory multiple sclerosis (MS). This specific RXR agonist, bexarotene, was found to help remyelination,…

Continue Reading Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis
Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
source: pixabay.com

Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete

According to a story from BioSpace, the biopharmaceutical company Clene Nanomedicine, Inc., has recently announced that it has completed the process of enrollment patient participants in its upcoming phase 2…

Continue Reading Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease
Source: Pixabay

Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

  Within the last month, BrainStorm Cell Therapeutics Inc. announced the publication of pre-clinical data on the NurOwn system. NurOwn technology produces autologous, bone marrow-derived mesenchymal stem cells (MSCs) for…

Continue Reading Preclinical Data Supports NurOwn for ALS, MS, and Alzheimer’s Disease

IVX Health Opens 3 Tampa-Based Infusion Centers to Treat MS and Other Chronic Conditions

Recently, IVX Health announced the opening of three new Tampa-based infusion centers to treat patients with chronic conditions. Currently, IVX Health, who describes themselves as "[providing] biologic injections and infusions…

Continue Reading IVX Health Opens 3 Tampa-Based Infusion Centers to Treat MS and Other Chronic Conditions
Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory
source: pixabay.com

Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory

by Caitlin Seida from In The Cloud Copy Those living with autoimmune disorders like uveitis and multiple sclerosis know all too well that the cells within our bodies meant to…

Continue Reading Protein Responsible for Inflammatory Uveitis May Also Be Anti-Inflammatory
Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases
source: pixabay.com

Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases

  According to an article in Science Alert first published in the journal The Conversation, researchers at the University of Birmingham have shown that it is possible to prevent the…

Continue Reading Scientists at the University of Birmingham are Researching Methods to Reverse Autoimmune Diseases
Moebius Syndrome Patient Explains How to Emote While Wearing a Mask
source: pixabay.com

Moebius Syndrome Patient Explains How to Emote While Wearing a Mask

Moebius Syndrome Moebius syndrome is a rare condition that causes an inability to move the eyes laterally and facial paralysis. A similar type of paralysis can also occur as a…

Continue Reading Moebius Syndrome Patient Explains How to Emote While Wearing a Mask
How Rogue Astrocytes Cause Neurodegeneration
GerryShaw / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

How Rogue Astrocytes Cause Neurodegeneration

  You have a number of different cells throughout your body, all of which perform different functions or provide support. One extremely interesting type are astrocytes, star-shaped glial cells that…

Continue Reading How Rogue Astrocytes Cause Neurodegeneration
1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
source: pixabay.com

1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases

Leszek Ignatowicz, a researcher from Georgia State University, recently received a 5 year, almost 2 million dollar grant from the NIH for his investigation into multiple sclerosis (MS). This project…

Continue Reading 1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment
source: pixabay.com

Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment

According to a story from Multiple Sclerosis News Today, the drug company Bristol-Myers Squibb recently announced that its drug ozanimod (marketed as Zeposia) is now available for public use in…

Continue Reading Relapsing Multiple Sclerosis Patients in the US Now Have Access to a New Treatment

Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis

The European Commission has recently granted approval to Bristol Myers Squibb (BMS) for their multiple sclerosis (MS) treatment, Zeposia. It has already been approved by the FDA in the US…

Continue Reading Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis
TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
mohamed_hassan / Pixabay

TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders

According to MedScape, tumor necrosis factor (TNF) inhibitors present severe issues for patients with autoimmune disorders. In particular, patients exposed to TNF inhibitors may experience inflammation throughout their central nervous…

Continue Reading TNF Inhibitors Increase Risk of Central Nervous System Inflammation for Patients with Autoimmune Disorders
Close Menu